{"name":"BioTech Tools S.A.","slug":"biotech-tools-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"gpASIT+TM","genericName":"gpASIT+TM","slug":"gpasit-tm","indication":"Metastatic melanoma","status":"phase_3"}]}],"pipeline":[{"name":"gpASIT+TM","genericName":"gpASIT+TM","slug":"gpasit-tm","phase":"phase_3","mechanism":"gpASIT+TM is a personalized immunotherapy that uses a patient's own immune cells to target and destroy cancer cells.","indications":["Metastatic melanoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-03","type":"pipeline","source":"simplywall.st","summary":"Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Biotech Tools And Cryo TEM Launches - simplywall.st","headline":"Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Biotech Tools And Cryo TEM Launches","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNRDQwY0U4WmZKR2h0cEF2Y01pUjJXcnlRczB5d2REV1VaQmMwSkpnbW9jUkE1QUExTjE0LXViQ2xSbS1OODVrRUlKblN2aVZhX1pmYTJJaER2bXo1M05Db21oanRrM2tBMVpRV2d5aXNyUHZuUFBDamFoYUNPbUZDS3BSNGtZeFpxREpaRzRSRUdiQVcxOTZLRVVxa3hxc0tEQmI2Sk8wb2VmMzc1LTcycWVJR3pibHBRMEswbUNB?oc=5","date":"2026-02-04","type":"pipeline","source":"AD HOC NEWS","summary":"UCB S.A. Stock: Can This Belgian Biotech Keep Its Rally Alive After A 12-Month Surge? - AD HOC NEWS","headline":"UCB S.A. Stock: Can This Belgian Biotech Keep Its Rally Alive After A 12-Month Surge?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFB6ZkJDUjcyZGJOY1E2QlJxZWRqZ0w3ZThjc3pyMk02V0tMQ29ZMVVxV3F3WFhQMU9EZG1NN0x5bG5udE5ScWJCbkdndDYzSXR6aGRzcXR1TC1vT0x0OWw3UFdleThrUQ?oc=5","date":"2025-10-20","type":"pipeline","source":"Anthropic","summary":"Claude for Life Sciences - Anthropic","headline":"Claude for Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxON2E4TVVSbTBvX05McFBjRjZtRXVaNmc0VjdjVC01OE56MzBpN1NCU0Z6R2pZLV9GenM1Q3FWcmdTREJXY3dqYTJFaW1zc2dlaXN4NXVFbHBWVVNBU0VaWGxSWlBzRHczc09EQUN5b295MEUyaGViMmZYTmtwZmtqSUpEUFh2eXZEMVAwbE1ZQ2FpaFVG?oc=5","date":"2025-09-15","type":"trial","source":"Frontiers","summary":"Technological and industrial trends in China’s pharmaceutical sector - Frontiers","headline":"Technological and industrial trends in China’s pharmaceutical sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQMWZKZzNPb2RzWEFBT3loUXlfYkt6bllTbTFGMUh6a184XzhmLThoa0dHRFcyOXNrbnRnb0dJR3puLXZIeUlMWk4tbGtMTUVhNHlZc3B6RlRxc0VyRHhDZUt1NHZtQTNRa1NtbV8tc3RWOFE1bGFGd1dvSjJZdFZCMVlSbXE5Si1od3BCSG10WWVfN0Z3LW5GTFc5c2Zfa3ZfeW84MkJjZHVjMVJrdTg1THZyWWF2d2hRMDljZkx5Y1ZCWHRmdWdJekU0SUJBdDBhSm1tcXBLb1pzQWZtMk9GdGdrLXhyblV4?oc=5","date":"2025-07-17","type":"pipeline","source":"BioSpace","summary":"Antibody Discovery Market Size to Surpass USD 20.4 Bn by 2034 Fueled by Precision Medicine and Biotech Innovation - BioSpace","headline":"Antibody Discovery Market Size to Surpass USD 20.4 Bn by 2034 Fueled by Precision Medicine and Biotech Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOMkR1SkFEdUlnWHdNU2ZuZy1xRXRNVTBXTzBvYlJMV2NZNUMtendNNXFWeWt4NExJc0tkZmJNT2RLczVQX2lUTTdhUzVpUGpPNVR5ZnQ0RkhCV29JdHRPMU1jdmQ1cl84S3UwTGdyNFJXUXNaa3hGZlBfc19haVdhVHRBcjBpc3AwOC0xUWszYzhKZFZPQkdfNkdDcy1mM1ZxOGVCT011YTZVOUhMVjhVc0lKQWZSYnBDa3dEZllXMkh4cG1oTzRWajVwRlE5aHNlQ24zUlVWZm5PUFdQRXhV?oc=5","date":"2025-07-14","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Recent NAM Guidelines Provide Much-Needed Step toward a More Productive Biotechnology Industry - Genetic Engineering and Biotechnology News","headline":"Recent NAM Guidelines Provide Much-Needed Step toward a More Productive Biotechnology Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5nemRrVzBESHlYcml4OE1lMzduSVNxcV9kTVRZVElLN3Jlb1Q5MzJBYlVmeGNYVmV3cmVZYXc3dENEN1pSUDJwNERsZExuVS1PSmpBQVVERW1SQW1kNUJRa3loaTlReFZxZmc?oc=5","date":"2025-06-30","type":"pipeline","source":"Intellectia AI","summary":"Top 5 Biotech Stocks Under $5 to Watch in 2025 - Intellectia AI","headline":"Top 5 Biotech Stocks Under $5 to Watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1DZjdoekVyaVZYS2xERTFCXzhVcVVLSkpESmh3bTRxc1Q0aC05UlRPTHp3bTJ1ZFZnRUhnY3kyOHFQX3lDUjF2N3p6cThET3NXaHlMcWhfS2hoVkZLbUV1OGR1c1MzNVpZOUZwNEF4OGpnRFN4QkE?oc=5","date":"2025-03-18","type":"pipeline","source":"Straits Research","summary":"High Throughput Screening Market Size & Trends | 2033 - Straits Research","headline":"High Throughput Screening Market Size & Trends | 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPaldaNFBQZ0paQjY3YjVmTFN5c2JlRVY4MEZzUm5fY2JkUlBZQlZvT1ppV2lmQTlTQWpSclVDRFpVY2g5cU4yTkVqb1owcjdxUTU3dHhPckdhdm13WFc3YXNRMktCSHlnSDNMeDM1WnZmQTdEUElOTjJ2ZVprTXByVUNLeENEYWtEWmE2Rk9LU2w1eWdqOWVjN2M1ZjNxLXlRakE?oc=5","date":"2024-12-06","type":"trial","source":"Clinical Trials Arena","summary":"Half of pharma and biotech companies using AI and big data - Clinical Trials Arena","headline":"Half of pharma and biotech companies using AI and big data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPR1FjZXpLbFJadkVMQzlOaHFUakZ6aEFLT3JPZXBpU05XVjRsMFQ0c2VYTzdfM3VVNmNRWlljeGN5WnBCdXBLbVNSeUVnQ3V5a0l5Rmw5SEtveEQ4bHNGNTdFazQ3N0xyRDFpeEw0NHJtM1I2eTZ5NUQ0ZmlWajRjblcxTmRVTFdzTk5jTDI2SEJnLWhU?oc=5","date":"2024-05-15","type":"pipeline","source":"novoholdings.dk","summary":"Novo Holdings A/S (“Novo Holdings”) today announced that it - novoholdings.dk","headline":"Novo Holdings A/S (“Novo Holdings”) today announced that it","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNbElTaUZJZkZvX2w1X3N3c0lsSHZmRnpIOTlCVjE4b3lJdXVtZFdzV210cDVjS241emxELVl3a181Y1Naai1WTzVOVThqOVBIZXkwcjNGSWNVMmRiX2RwMkpUZkhod2ZPQWx5VERySWVYakdOc3dkUUt4ZE16ZXJILW1DZF8tUHJBU0FyTGZZSjRXQWtvOF82RzIwNTlrcmdU?oc=5","date":"2024-01-31","type":"patent","source":"Inventa","summary":"Pharma and Biotech Patent Litigation Summit 2024 - Inventa","headline":"Pharma and Biotech Patent Litigation Summit 2024","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}